HealthPartners plans to resume enrollment for AstraZeneca's Covid-19 vaccine trials

The FDA authorized AstraZeneca last Friday to restart trials that were paused in September.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.